107 related articles for article (PubMed ID: 10456617)
1. Alterations to the fibrinolytic enzyme system in patients with non-small cell lung carcinoma.
Pavey SJ; Hawson GA; Marsh NA
Blood Coagul Fibrinolysis; 1999 Jul; 10(5):261-7. PubMed ID: 10456617
[TBL] [Abstract][Full Text] [Related]
2. Impact of the fibrinolytic enzyme system on prognosis and survival associated with non-small cell lung carcinoma.
Pavey SJ; Hawson GA; Marsh NA
Blood Coagul Fibrinolysis; 2001 Jan; 12(1):51-8. PubMed ID: 11229827
[TBL] [Abstract][Full Text] [Related]
3. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
[TBL] [Abstract][Full Text] [Related]
4. Blood and tissue fibrinolytic profiles in patients with colorectal carcinoma.
Montemurro P; Conese M; Altomare DF; Memeo V; Colucci M; Semeraro N
Int J Clin Lab Res; 1995; 25(4):195-200. PubMed ID: 8788547
[TBL] [Abstract][Full Text] [Related]
5. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
[TBL] [Abstract][Full Text] [Related]
6. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
[TBL] [Abstract][Full Text] [Related]
7. Lack of correlation between blood fibrinolysis and the immediate or post-operative blood loss in transurethral resection of the prostate.
Nielsen JD; Gram J; Fabrin K; Holm-Nielsen A; Jespersen J
Br J Urol; 1997 Jul; 80(1):105-10. PubMed ID: 9240188
[TBL] [Abstract][Full Text] [Related]
8. Extrinsic plasminogen activator: a new principle in fibrinolysis.
Lijnen HR
Behring Inst Mitt; 1983 Aug; (73):43-55. PubMed ID: 6236789
[TBL] [Abstract][Full Text] [Related]
9. Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus.
Carmassi F; Morale M; Puccetti R; De Negri F; Monzani F; Navalesi R; Mariani G
Thromb Res; 1992 Sep; 67(6):643-54. PubMed ID: 1440530
[TBL] [Abstract][Full Text] [Related]
10. Coagulation-fibrinolysis system in poststroke patients receiving antiplatelet medication.
Tohgi H; Takahashi H; Chiba K; Tamura K
Stroke; 1993 Jun; 24(6):801-4. PubMed ID: 8506551
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activators in alcoholic cirrhosis: demonstration of increased tissue type and urokinase type activator.
Booth NA; Anderson JA; Bennett B
J Clin Pathol; 1984 Jul; 37(7):772-7. PubMed ID: 6235248
[TBL] [Abstract][Full Text] [Related]
12. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
[TBL] [Abstract][Full Text] [Related]
13. Association between uremic toxin-anthranilic acid and fibrinolytic system activity in predialysis patients at different stages of chronic kidney disease.
Kaminski TW; Pawlak K; Karbowska M; Mysliwiec M; Grzegorzewski W; Kuna J; Pawlak D
Int Urol Nephrol; 2018 Jan; 50(1):127-135. PubMed ID: 29058166
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
Matsuo O; Rijken DC; Collen D
Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays.
Camiolo SM; Greco WR
Cancer Res; 1986 Apr; 46(4 Pt 1):1788-94. PubMed ID: 3081257
[TBL] [Abstract][Full Text] [Related]
16. Increased incorporation of antiplasmin into the fibrin network in patients with type 1 diabetes.
Agren A; Jörneskog G; Elgue G; Henriksson P; Wallen H; Wiman B
Diabetes Care; 2014 Jul; 37(7):2007-14. PubMed ID: 24760258
[TBL] [Abstract][Full Text] [Related]
17. Activation of the fibrinolytic system in patients with fulminant liver failure.
Pernambuco JR; Langley PG; Hughes RD; Izumi S; Williams R
Hepatology; 1993 Dec; 18(6):1350-6. PubMed ID: 8244260
[TBL] [Abstract][Full Text] [Related]
18. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
Munkvad S
Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
[TBL] [Abstract][Full Text] [Related]
19. Postoperative hypercoagulable state followed by hyperfibrinolysis related to wound healing after hepatic resection.
Tsuji K; Eguchi Y; Kodama M
J Am Coll Surg; 1996 Sep; 183(3):230-8. PubMed ID: 8784316
[TBL] [Abstract][Full Text] [Related]
20. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis.
Kario K; Matsuo T
Atherosclerosis; 1993 Nov; 103(2):131-8. PubMed ID: 8292090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]